Evolution Wealth Advisors’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-73
Closed -$4K 656
2021
Q3
$4K Sell
73
-112
-61% -$5.86K ﹤0.01% 583
2021
Q2
$9K Hold
185
﹤0.01% 432
2021
Q1
$9K Hold
185
﹤0.01% 437
2020
Q4
$12K Sell
185
-30
-14% -$1.86K ﹤0.01% 333
2020
Q3
$14K Sell
215
-79
-27% -$4.31K ﹤0.01% 315
2020
Q2
$12K Sell
294
-102
-26% -$3.92K ﹤0.01% 267
2020
Q1
$12K Buy
+396
New +$15.9K ﹤0.01% 200

Other funds holding SILK

Evolution Wealth Advisors's SILK Position: Q4 2021 in Review

Evolution Wealth Advisors sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q4 2021, closing a stake of 73 shares — an estimated $4K sold.

Evolution Wealth Advisors first reported a position in SILK in Q1 2020 and held it in 7 quarters. The position peaked at $14K in Q3 2020. 152 funds tracked by Wall St. Rank hold SILK as of Q4 2021.

  • Evolution Wealth Advisors reported no remaining Silk Road Medical, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Evolution Wealth Advisors sold 73 Silk Road Medical, Inc. Common Stock shares in Q4 2021, an estimated $4K.
  • Evolution Wealth Advisors first reported a position in Silk Road Medical, Inc. Common Stock in Q1 2020 and held it in 7 quarters.
  • Evolution Wealth Advisors's Silk Road Medical, Inc. Common Stock position peaked at $14K in Q3 2020.
  • 152 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q4 2021.

Based on Evolution Wealth Advisors's 13F filing for Q4 2021, filed 28 Jan 2022.